Compare CPRT & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRT | TEVA |
|---|---|---|
| Founded | 1982 | 1901 |
| Country | United States | Israel |
| Employees | N/A | 32842 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2B | 33.5B |
| IPO Year | 1996 | N/A |
| Metric | CPRT | TEVA |
|---|---|---|
| Price | $33.30 | $31.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $44.40 | $38.63 |
| AVG Volume (30 Days) | ★ 6.8M | 4.8M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.57 | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $1,805,695,000.00 | N/A |
| Revenue This Year | $1.23 | N/A |
| Revenue Next Year | $4.68 | $3.24 |
| P/E Ratio | $43.29 | ★ $28.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.20 | $13.04 |
| 52 Week High | $63.77 | $37.35 |
| Indicator | CPRT | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 54.69 |
| Support Level | $32.20 | $30.70 |
| Resistance Level | $33.99 | $31.99 |
| Average True Range (ATR) | 0.75 | 0.88 |
| MACD | 0.23 | 0.33 |
| Stochastic Oscillator | 54.93 | 82.96 |
Based in Dallas, Copart operates an online salvage vehicle auction with operations in 11 countries across North America, Europe, and the Middle East, facilitating over 4 million transactions annually. The company utilizes its virtual bidding platform, VB3, to connect vehicle sellers with over 750,000 registered buyers around the world. Buyers primarily consist of vehicle dismantlers, rebuilders, individuals and used vehicle retailers. About 80% of Copart's vehicle volume is supplied by auto insurance companies holding vehicles deemed a total loss. Copart also offers services such as vehicle transportation, storage, title transfer, and salvage value estimation. The company primarily operates on a consignment basis and collects fees based on the vehicle's final selling price.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.